HANSOH PHARMA (03692): Zeng Zhao was appointed as the joint company secretary and authorized representative.
Johnson Pharmaceuticals (03692) announced that Mr. Li Liangxian has resigned from his position as Joint Company Secretary due to personal work arrangements. He will no longer serve as the authorized representative of the company under Rule 3.05 of the Listing Rules of The Stock Exchange of Hong Kong Limited, as well as the authorized representative of the company for receiving legal process documents and notices in Hong Kong under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance (Chapter 622 of the laws of Hong Kong) (legal process agent), effective from May 15, 2026.
Hansoh Pharma (03692) announced that Mr. Li Liangxian has resigned from the position of Co-Secretary of the company due to personal work arrangements, and will no longer serve as the authorized representative of the company under Rule 3.05 of the Listing Rules of The Stock Exchange of Hong Kong Limited, as well as the authorized representative of the company for receiving legal process and notices in Hong Kong under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), effective from May 15, 2026.
Ms. Zeng Zhao has been appointed as the Co-Secretary, authorized representative, and legal process agent of the company, effective from May 15, 2026.
Related Articles
CHIHO ENV(00976): Situ Yuting and Leung Pui Yee resign as Independent Non-Executive Directors.
CAOCAO INC (02643) spent HK$8,009,600 to repurchase 341,400 shares on May 15th.
CAPITAL FIN (08239): Wang Minghui resigns as Executive Director of the company.
CHIHO ENV(00976): Situ Yuting and Leung Pui Yee resign as Independent Non-Executive Directors.
CAOCAO INC (02643) spent HK$8,009,600 to repurchase 341,400 shares on May 15th.
CAPITAL FIN (08239): Wang Minghui resigns as Executive Director of the company.
